The CompanionCBD offering is now closed and is no longer accepting investments.

CompanionCBD

Manufacturing CBD-based soft chews for the companion animal health market...

CompanionCBD

Manufacturing CBD-based soft chews for the companion animal health market...

Scottsdale, AZ
Consumer Products
CompanionCBD is a veterinarian-owned and operated company. CBD can help manage anxiety, pain, seizures, neuro-degenerative conditions and more in pets. We believe, the therapeutic potential of CBD in the marketplace—as it pertains to veterinary care, especially—is untapped. This is due to the current market’s fascination with CBD “treats,” none of which contain enough compound to provide real therapeutic benefits. Our soft chew, while extremely palatable to the pet due to its cheesy-bread flavor, delivers science-based concentrations of CBD capable of producing tangible, documentable therapeutic results.

$18,223

raised
40
Investors
$3.9M
Valuation
$1.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left

$18,223

raised
40
Investors
$3.9M
Valuation
$1.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left
This offering ended on March 21, 2020 and is no longer accepting investments.

Reasons to Invest

Dr. Josh Sosnow pioneered the research, development, and education of CBD in the veterinary market.
Dr. Sosnow created one of the first Registry of Approved Continuing Education (RACE®)-approved series on CBD. Over 5000 veterinarians have taken the course.
Veterinarian-owned company with a proven track record of sales since Oct. 2018. Our products are veterinarian-approved and endorsed. Products are sold at veterinary hospitals and retailers alike across the US.

Current CBD products fail to cater to pets’ specific needs.

Most CBD offerings fail to provide the dosing flexibility necessary to treat any health condition in our pets. Additionally, many products prove both unpalatable to animals and prohibitively expensive. In response, owners have turned to giving their pets unverified and often adulterated “street” products which can contain undisclosed amounts THC (which can prove toxic to pets) and other contaminants, including heavy metals.

CompanionCBD is veterinarian-approved and loved by pets.

Our tasty, cheese-flavored soft chews make CBD a reward, not a chore. Pets love them. Additionally, the chews include other evidence-based active ingredients for a more complete approach to managing a condition. 

Dosing is vital when targeting specific organs or conditions, but dogs come in all shapes, sizes and weights. Our products solve this problem, as we offer a range of concentrations at 5, 10, 20 and 40mg of CBD per chew. Our “Ask a Vet” feature empowers pet owners to conference with a veterinarian to determine their pet’s specific dosing needs.

Our Current Product Line

C3, our next generation product line with additional evidence-based ingredients. Production for Q1 2020

Equis CBD for the equine market in production for Q1 2020.

CBD is taking the pet health community by storm

CBD is one of the fastest-growing topics to take hold in the pet health community. With the proliferation of companies entering this space, pet owners are clamoring for products they can trust.


  • CBD pet products could balloon to a $1.16 billion industry in the U.S. by 2022, the Brightfield Group estimates. Last year, Americans spent $33 billion on pet food and treats alone, according to Nielsen.

  • $33 billion of overall spending is made up by OTC products, medications and veterinary care.

  • Sales of CBD pet products quadrupled last year to $32 million from $8 million in 2017, according to the Brightfield Group.

We are sharing the scientific benefits of CBD on a national platform

Over the last year, we have steadily gained support within the veterinary community. Product sales and the number of participating veterinarians have consistently grown since the start of 2019. We have exhibited at multiple veterinary conferences and lectured to the veterinary community about the science of CBD and on national platforms.


  • We believe CompanionCBD is the only veterinarian-owned company to offer a diverse line of products with multiple offerings and concentrations.

  • We are the first company to have produced nationally recognized, RACE®­approved CBD continuing education for the veterinary community via the Vetmed Team.

  • Globally, over 5,000 veterinarians and veterinary technicians have completed our continuing education courses. New educational courses release in Q1 of 2020.

Featured on "The List" along with 30+ national publications this year alone!

Testimonials

We make healthy, healing and delicious CBD products for pets

We use the latest advancements in cannabis science to create clinically effective products. Our secret is no secret, though. We simply include enough CBD to make a real difference. CBD is used to manage a variety of conditions like osteoarthritis, seizures, anxiety, GI-related issues and neuropathic/chronic pain. Our products are effective, and dogs and cats love them!

With the ability to target both pet owners and veterinarians, we have multiple revenue streams

For pet owners, with our expanding product line, we create product specifically designed for the individual needs of each pet. 

For veterinarians, we look to be their “go-to” CBD partner. We provide everything a hospital needs to accurately utilize CBD and educate clients, including product, tools, digital infrastructure and legal guidance.

A Game-Changing Veterinary Portal for the Pet Owner


We are proud to have recently released our unique "Ask a Vet" feature on our website. This allows pet owners to schedule a veterinary consultation to determine which product will meet the specific needs of their pet. This private-server video conference is provided free of charge to enhance the value of the product and ensure correct dosing strategy.

Unique Tools for the Veterinary Practice

Products to ensure accurate dosage, and an "Ask a Vet" portal

Most of our competitors offer tinctures (oil-based products) which are inadequately dosed and cost-prohibitive to be administered on a regular basis. Unlike these companies, we make the most affordable product on the market—one easy for owners to administer and dosed to accurately reflect the published science of CBD. 


To ensure safety and efficacy, we test our products with independent labs three times, twice prior to manufacturing. Then, the final product undergoes rigorous scrutiny to determine both the exact concentration of active CBD and whether any contaminants exist. To our knowledge, we represent the only veterinarian-owned CBD manufacturer that produces products in a cGMP/FDA approved facility and is also certified by the National Animal Supplement Council.

We will use our research to create advanced products

Our growth focuses on the development of customized product lines. We have formulated and will launch additional CBD products combined with other active ingredients. These directly target a variety of conditions that CBD alone is currently used to manage. These product lines are evidenced-based and bring together active ingredients that currently must be administered separately.

We are veterinarians, researchers and animal lovers

Collectively, we bring a strong knowledge of veterinary medicine, clinical experience with phytocannabinoids, knowledge of medical device/pharmaceutical distribution and a strong background in the technological aspects of building a company to CompanionCBD. We have leveraged our experience to provide the foundation (i.e. education) for the pet health community to understand how these compounds work in the body, and thereby understand how our products can play an effective role in managing the targeted condition.

We’ve found the weaknesses in the market and are here to provide something better

Veterinarian-owned company with a proven track record of sales since Oct. 2018. Our products are veterinarian-approved and endorsed. Products are sold at veterinary hospitals and retailers alike across the US.

Our retail division has commitments with CBD retail stores, pet stores, natural food stores, dispensaries and more pending. 

Dr. Sosnow has created the first continuing education (CE) platform to educate veterinarians and supporting staff, via Vetmed. Dr. Sosnow speaks on a national level to educate doctors, retailers and pet owners.

Other evidence-based products launching Q1 of 2020 to create additional revenue streams. 

All products are: Easy to administer; effectively dosed per condition(s); tested independently three times for safety and efficacy; loved by pets, and affordable to the pet owner.

One of the first, if not the first, veterinarian-owned CBD manufacturer of pet products.

The pet market is saturated with poorly formulated, unpalatable and weakly-dosed products. The full benefit of CBD can only be realized when it is easy to administer long-term, dosed appropriately for the targeted condition(s) and is affordable to the pet owner. Our products satisfy all these conditions.

Offering Summary


Company

:

Companion CBD, Inc.

Corporate Address

:

14870 N Northsight Blvd, Scottsdale, AZ 85260

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,070,000.00

Minimum Investment Amount

(per investor)

:

$250.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

10,000

Maximum Number of Shares Offered

:

1,070,000

Price per Share

:

$1.00

Pre-Money Valuation

:

$3,900,000.00











*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below

Perks* and Investment Bonuses

Early Bird

First 48 hours - 10% bonus shares

Next 5 days - 5% bonus shares

Volume

$500+ (Access to Owners group where you get early access to products, new releases and early feedback

$1,000 (100 in store credit)

$2,500+ (5% bonus shares + and $250 in store credit)

$5,000+ (10% bonus shares and $500 in store credit)

$20,000+ (15% bonus shares + $1,000 in store credit)

*All perks occur after the offering is completed

The 10% Bonus for StartEngine Shareholders

CompanionCBD will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 500 shares of Common Stock at $5 / share, you will receive 50 bonus shares of Common Stock, meaning you'll own 550 shares for $500. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are cancelled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Salary payments made to one’s self, a friend or relative.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$154,628.00 USD
$0.00 USD
Cash And Cash Equivalents
$67,493.00 USD
$0.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$6,503.00 USD
$0.00 USD
Long Term Debt
$0.00 USD
$0.00 USD
Revenues And Sales
$18,261.00 USD
$0.00 USD
Costs Of Goods Sold
$5,074.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$90,675.00 USD
$0.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Notice of Funds Disbursement

over 1 year ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, CompanionCBD has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in CompanionCBD be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Important facts about why we are the trusted and endorsed name brand in vet medicine...

over 1 year ago

Hi!

As we all know, CBD has become the most talked about topic in veterinary medicine.  We also know the upside to this multi-billion dollar industry. That said, their is a significant amount of mis-information being told by uneducated people, that are not trained in CBD or even in the animal health industry.  

Our business model was created based on our due diligence in the marketplace, and what we saw was need to provide safe, effective quality products for the welfare of animals everywhere.


Here is why we are the trusted name and endorsed by veterinarians and vet hospitals:

* We are the only veterinarian owed and run CBD manufacture, specializing in CBD for animals.

* Our products are made in a cGMP/FDA approved facility and certified by the National Animal Supplement Council.

* Our products are triple lab tested by third party labs post manufacturing, to ensure safety, quality and value.

* Dr. Sosnow, Co-founder and Chief Medical Officer, created the first nationally accredited continuing education course for vet medicine. Over 7,000 vets globally have taken his courses.

* Our products are formulated based on the science of CBD and studies have shown CBD to be effective in many different conditions.

* We control the entire manufacturing process, which gives us the ability to provide the safest, most effective and best pricing for our customers.

* Multiple NEW product lines coming soon!


We appreciate your support!


Brad Malin

Co-Founder and CEO

CompanionCBD Inc.

CompanionCBD.com

Pet Loving CBD fans suggest a green future for hemp.

over 1 year ago

A Neilson survey shows more and more owners are giving CBD products to their pets despite open questions about regulations....

Sales of hemp-based CBD products for pets are on the rise, and this trend is not expected to slow down anytime soon. This is according to Nielsen and Headset's 2020 Pet Industry Green Paper, which predicts CBD pet products will represent as much as 5% of all hemp CBD sales within the U.S. by 2025.

These products, Nielsen reports have already generated more than 9.4 million in combined sales at regulated adult-use cannabis retailers in just California, Colorado, Nevada and Washington.


Other Key findings to the report include:

74% of those who purchase CBD have pets.

24% of pet owners say they already use hemp/CBD products themselves, their pets or both.

The paper, says Maria Lange, Nielsen's VP of strategic initiatives, offers perspective on the rapidly evolvingCBD product landscape and it's buyers, allowing companies to capitalize on the emerging trends, and potential opportunities.

"Understading the dynamics at play in the cannabis space and thier impact on the pet industry is critical," she says. "Despite open questions around regulations, hemp-CBD is exploding in the pet industry."

The growth is astounding from where it was two years ago.  We are in the right space at the right time.



Notice of Funds Disbursement

over 1 year ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, CompanionCBD has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in CompanionCBD be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

CompanionCBD, Inc. Investor Update

over 1 year ago

Hello,

Welcome to the CompanionCBD family!  We are more than grateful for your investment and support.

We are excited that we just reached our minimum funding goal.  We also just received word that a large retailer is very interested in carrying our products.  More on that later...

We will be launching our equine (horse) CBD product soon!  We have strong ties in the space.  We have been trialing different formulations for the last 6 months and finally, have the right formulation ready to go!  As soon as we can raise the necessary capital, we envision to have this new product available by April 2020.

Please share our story with your friends and family.  We are still offering our 10% bonus shares for early investors.  This will soon expire.  Much more slated this year with other product lines to be brought to the public.

We will also be updating our campaign page with new content and a video.  Stay tuned for that!



Regards,

Brad Malin

CEO/Co-Founder

CompanionCBD, Inc.



Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}